<DOC>
	<DOCNO>NCT00169728</DOCNO>
	<brief_summary>The purpose study determine immunogenicity tolerability DTaP-IPV-HBV/Hib combination vaccine Infanrix hexa heptavalent pneumococcal conjugate vaccine Prevenar pediatric recipient allogeneic haematopoietic stem cell transplantation .</brief_summary>
	<brief_title>Vaccination Children Following Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>pediatric recipient allogeneic haematopoietic stem cell transplantation complete remission underlie malignant disease ( applicable ) stable haematopoietic engraftment Lansky/Karnofskyscore &gt; = 60 % primary immunodeficiency hepatitis B C , HIV infection application radio/ chemotherapy follow stem cell transplantation extend chronic graftversushost disease ( Karnofskyscale &lt; 60 % ) coagulopathy know allergy/hypersensitivity towards ingredient study vaccine seizure disorder , progressive neurologic disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>allogeneic haematopoietic stem cell transplantation</keyword>
	<keyword>bone marrow transplantation</keyword>
	<keyword>child</keyword>
	<keyword>vaccination</keyword>
	<keyword>invasive pneumococcal disease</keyword>
	<keyword>tetanus</keyword>
	<keyword>diphtheria</keyword>
	<keyword>poliomyelitis</keyword>
	<keyword>pertussis</keyword>
	<keyword>Hepatitis B</keyword>
	<keyword>Haemophilus influenzae type B infection</keyword>
</DOC>